CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an autograft: Early results from a pilot study-Reference-Cited by-同舟云学术

CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an autograft: Early results from a pilot study

Published:2019-09 Issue: Volume:77 Page:26-35.e1
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Jaiswal Sarita Rani^ORCID,Aiyer Hema Malini^ORCID,Rawat Garima,Gera Arun,Chakrabarti Suparno

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference25 articles.

1. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation;Fenske;Br J Haematol,2016

2. Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: A Center for International Blood and Marrow Transplant Research Analysis;Ghosh;J Clin Oncol,2016

3. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL;Dreger;Blood Adv,2019

4. The future of kinase inhibitors for DLBCL?;Herman;Blood,2018

5. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1–2 trial;Locke;Lancet Oncol,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors;JTO Clinical and Research Reports;2023-10

2. Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease;Frontiers in Hematology;2023-08-03

3. Facing challenges with hope: universal immune cells for hematologic malignancies;Cancer Biology & Medicine;2023-05-04

4. Hematopoietic Cell Transplantation for Sickle Cell Disease;Frontiers in Pediatrics;2021-01-05

5. Haploidentical Transplantation: Challenges and Solutions;Contemporary Bone Marrow Transplantation;2021